Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Purinogenic Immunodeficiency Diseases: DIFFERENTIAL EFFECTS OF DEOXYADENOSINE AND DEOXYGUANOSINE ON DNA SYNTHESIS IN HUMAN T LYMPHOBLASTS
James M. Wilson, … , Peter E. Daddona, William N. Kelley
James M. Wilson, … , Peter E. Daddona, William N. Kelley
Published November 1, 1979
Citation Information: J Clin Invest. 1979;64(5):1475-1484. https://doi.org/10.1172/JCI109606.
View: Text | PDF
Article has an altmetric score of 6

Purinogenic Immunodeficiency Diseases: DIFFERENTIAL EFFECTS OF DEOXYADENOSINE AND DEOXYGUANOSINE ON DNA SYNTHESIS IN HUMAN T LYMPHOBLASTS

  • Text
  • PDF
Abstract

Deoxyadenosine and deoxyguanosine are toxic to human lymphoid cells in culture and have been implicated in the pathogenesis of the immunodeficiency states associated with adenosine deaminase and purine nucleoside phosphorylase deficiency, respectively. We have studied the relative incorporation of several labeled nucleosides into DNA and into nucleotide pools to further elucidate the mechanism of deoxyribonucleoside toxicity. In the presence of an inhibitor of adenosine deaminase [erythro-9-(2-hydroxy-3-nonyl)adenine [EHNA], 5 μM], deoxyadenosine (1-50 μM) progressively decreased the incorporation of thymidine, uridine, and deoxyuridine into DNA, but did not affect uridine incorporation into RNA. This decrease in DNA synthesis was associated with increasing dATP and decreasing dCTP pools. Likewise, incubation of cells with deoxyguanosine caused an elevation of dGTP, depletion of dCTP, and inhibition of DNA synthesis.

Authors

James M. Wilson, Beverly S. Mitchell, Peter E. Daddona, William N. Kelley

×

Total citations by year

Year: 2021 2013 2007 2006 2003 2000 1999 1996 1995 1994 1990 1988 1987 1986 1985 1984 1983 1981 1980 1979 Total
Citations: 1 1 1 1 1 1 1 1 2 1 1 1 1 2 3 7 4 6 2 1 39
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (39)

Title and authors Publication Year
Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones
T Uchiyama, S Takahashi, K Nakabayashi, K Okamura, K Edasawa, M Yamada, N Watanabe, E Mochizuki, T Yasuda, A Miura, M Kato, D Tomizawa, M Otsu, T Ariga, M Onodera
Molecular Therapy — Methods & Clinical Development 2021
"Reverse" carbocyclic fleximers: synthesis of a new class of adenosine deaminase inhibitors
SC Zimmermann, JM Sadler, PI O'Daniel, NT Kim, KL Seley-Radtke
Nucleosides Nucleotides & Nucleic Acids 2013
Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency
S Delicou, V Kitra-Roussou, J Peristeri, E Goussetis, G Vessalas, E Rigatou, F Psychou, K Salavoura, S Grafakos
Pediatric Transplantation 2007
Advances in Enzymology - and Related Areas of Molecular Biology
H Waelsch
Advances in Enzymology and Related Areas of Molecular Biology 2006
Tomato juice inhibits adenosine deaminase activity in human prostate tissue from patient with prostate cancer
İ Durak, H Biri, A Avcı, S Sözen, E Devrim
Nutrition Research 2003
Adenosine Deaminase Prefers a Distinct Sugar Ring Conformation for Binding and Catalysis: Kinetic and Structural Studies
H Ford, F Dai, L Mu, MA Siddiqui, MC Nicklaus, L Anderson, VE Marquez, JJ Barchi
Biochemistry 2000
Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination
L Gangi-Peterson, DH Sorscher, JW Reynolds, TB Kepler, BS Mitchell
Journal of Clinical Investigation 1999
Primary Immunodeficiency Disorders: Pathogenesis and Treatment
MM Eibl, HM Wolf
Clinical immunotherapeutics 1996
Immunoglobulin Genes
PD Burrows, HW Schroeder, MD Cooper
Immunoglobulin Genes 1995
Interaction between ABO blood groups and ADA genetic polymorphism during intrauterine life: A comparative analysis of couples with habitual abortion and normal puerperae delivering a live-born infant
N Lucarini, M Nicotra, F Gloria-Bottini, P Borgiani, A Amante, C Muttinelli, F Signoretti, ML Torre, E Bottini
Human Genetics 1995
Adenosine deaminase, 5′-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis
I Durak, N Örmeci, Ö Akyol, O Canbolat, M Kavutçu, M Bülbül
Digestive Diseases and Sciences 1994
Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP
DS Duan, T Nagashima, T Hoshino, F Waldman, K Pawlak, W Sadee
Biochemical Journal 1990
Approaches to Gene Therapy in Disorders of Purine Metabolism
JA Wolff, T Friedmann
Rheumatic diseases clinics of North America 1988
Activities of purine metabolising enzymes in lymphocytes of neonates and young children: correlates with immune function
JA Renouf, YH Thong, AH Chalmers
Immunology Letters 1987
Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts
GJ Mann, RM Fox
Journal of Clinical Investigation 1986
Evaluation of adenosine deaminase activity in patients with head and neck cancer
KS Dasmahapatra, HZ Hill, A Dasmahapatra, S Suarez
Journal of Surgical Research 1986
Biochemical Consequences of Adenosine Deaminase Inhibition in Vivo
BS Mitchell, Y Sidi, M Hershfield, CA Koller
Annals of the New York Academy of Sciences 1985
Changes in deoxynucleoside triphosphate pools induced by inhibitors and modulators of ribonucleotide reductase
RM Fox
Pharmacology & Therapeutics 1985
Immunodeficiencies Associated with Errors in Purine Metabolism
NL Edwards
Medical Clinics of North America 1985
2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation
Y Sidi, BS Mitchell
Journal of Clinical Investigation 1984
The effect of G2-treatments with 2?-deoxyadenosine on the frequency of chromatid aberrations in human lymphocytes depends on the type of culture
BA Kihlman, HC Andersson
Chromosoma 1984
Effect of combinations of deoxyguanosine and 8-aminoguanosine with 2,3-dihydro-1H-imidazo[1,2-b]pyrazole on L1210 cell crowth in culture
A Sato, PE Bacon, SW Schneller, JG Cory
Biochemical Pharmacology 1984
The mechanism of inhibition and “reversal” of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency
D Albert, HG Bluestein, RC Willis, K Nette, JE Seegmiller
Cellular Immunology 1984
Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes
HA Simmonds, A Goday, GS Morris, M Foppe, J Brolsma
Biochemical Pharmacology 1984
Altered cell cycle distributions of cultured human lymphoblasts during cytotoxicity related to adenosine deaminase inhibition
J Faller, TD Palella, P Dean, IH Fox
Metabolism 1984
In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA
MF Siaw, MS Coleman
The Journal of biological chemistry 1984
The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency
WR Osborne, CR Scott
Biochemical Journal 1983
Metabolism of purine nucleosides in human and ovine lymphocytes and rat thymocytes and their influence on mitogenic stimulation
GJ Peters, A Ooterhof, JH Veerkamp
Biochimica et Biophysica Acta (BBA) - General Subjects 1983
Effect of purine nucleoside phosphorylase substrates on the mitogen-induced stimulation of murine T and B spleen cells
R Martineau, J Willemot
Immunopharmacology 1983
Effect of immunosuppressive agents on human T and B lymphoblasts
IS Kazmers, PE Daddona, AP Dalke, WN Kelley
Biochemical Pharmacology 1983
Consequences of adenosine deaminase deficiency on thymocyte metabolism
L Thuillier, F Garreau, PH Cartier
European Journal of Immunology 1981
Metabolic basis for disorders of purine nucleotide degradation
IH Fox
Metabolism 1981
Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts
PE Daddona, WN Kelley
Biochimica et Biophysica Acta (BBA) - Enzymology 1981
Deoxycoformycin: Neurological toxicity
PP Major, RP Agarwal, DW Kufe
Cancer Chemotherapy and Pharmacology 1981
Adenosine deaminase polymorphism. Associations at clinical level suggest a role in cell functions and immune reactions
E Bottini, E Carapella, L Cataldi, M Nicotra, P Lucarelli, N Lucarini, R Pascone, F Gloria-Bottini
Journal of medical genetics 1981
Inhibition of Purine Nucleoside Phosphorylase by 8-Aminoguanosine: Selective Toxicity for T Lymphoblasts
IS Kazmers, BS Mitchell, PE Dadonna, LL Wotring, LB Townsend, WN Kelley
Science 1981
ATP depletion as a consequence of adenosine deaminase inhibition in man
MF Siaw, BS Mitchell, CA Koller, MS Coleman, JJ Hutton
Proceedings of the National Academy of Sciences 1980
Purine Nucleoside Phosphorylase Deficiency: Improved Metabolic and Immunologic Function with Erythrocyte Transfusions
KC Rich, E Mejias, IH Fox
New England Journal of Medicine 1980
Contemporary Metabolism
N Freinkel
1979

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
2 readers on Mendeley
See more details